Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 25,112 shares at $284.44 ($7.1M) on 2023-04-28, disclosed to the SEC on 2023-05-02.
Seasonal sale ($7.1M) by EVP and Chief Clinical Officer — this insider has traded HCA in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $284.44 | 12,556 | $3.6M | 50.0% |
| 2 | $284.44 | 12,556 | $3.6M | 50.0% |
| Total | $284.44 avg | 25,112 | $7.1M | 100% |
| Filing → |
| HCA | SELL | 2024-09-12 | $6.4M | — | Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |